BioSpace News Archive

Business

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2018 Results Presentation and Webcast

Nordic Nanovector ASA announces its second quarter and first half 2018 results on Wednesday, 22 August 2018.

August 8, 2018
·
2 min read
Biotech Bay

Agilent Announces Update on PD-L1 CE-IVD in Urothelial Carcinoma

PD-L1 IHC 22C3 pharmDx Can Now Be Used as an Aid to Identify Urothelial Carcinoma Patients for Treatment With KEYTRUDA® (pembrolizumab)

August 8, 2018
·
2 min read
Frankfurt’s Clearstream Banking Lifts Settlement Restrictions on Securities Active in Medical Cannabis

Has revised its decision to now solely deal with companies focused on medical cannabis such as Veritas.

August 8, 2018
·
2 min read
Bio NC

National Day Calendar Declares August 8th National CBD Day, Chooses cbdMD as Official Sponsor

Due to the immense popularity of CBD, the National Day Calendar has officially declared today, August 8th, National CBD Day.

August 8, 2018
·
1 min read
Business

Verdeca Introduces Drought Tolerant Soybeans in Argentina

Verdeca’s HB4® soybean trait to help growers overcome challenging climate conditions

August 8, 2018
·
4 min read
Women Score Top Marks in The Leukemia & Lymphoma Society of Canada’s 2018 Research Awards

Female scientists lead scorers among 32 grant awardees in annual research competition held by Canada’s only nonprofit health agency dedicated to all blood cancers.

August 8, 2018
·
2 min read
Deals

VolitionRx Announces $9 Million Private Placement

VolitionRx Limited announced that it has entered into a definitive agreement with an existing accredited investor related to a private placement offering (PIPE) of 5 million shares of Volition common stock at a price of $1.80 per share

August 8, 2018
·
5 min read
Deals

WellCare Announces Pricing of 4,528,302 Shares of Its Common Stock

WellCare Health Plans, Inc. announced that on August 7, 2018 it priced an offering of 4,528,302 shares of its common stock at a public offering price of $265.00 per common share.

August 8, 2018
·
5 min read
Deals

Apexigen Raises $73 Million In Series B And Series C Financings

Proceeds to Support Ongoing Phase 2 Clinical Trials of Immuno-oncology Therapeutic APX005M and the Discovery and Development of a Pipeline of Novel Therapies

August 8, 2018
·
2 min read
Business

Soligenix Announces Recent Accomplishments And Second Quarter 2018 Financial Results

Soligenix, Inc. announced its recent accomplishments and financial results for the second quarter ended June 30, 2018.

August 8, 2018
·
7 min read